Alexis Valentin Rodriguez, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: B-10 Calle Magnolia, Urb. El Dorado, Guayama, PR 00784 Phone: 787-864-3718 |
Dr. Emilio Paez, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: Urb. Costa Azul, 2do Piso Suite 204 & 206, Guayama, PR 00784 Phone: 787-416-1560 Fax: 787-416-1563 |
Spinal Rehab Centers Csp Chiropractor Medicare: Not Enrolled in Medicare Practice Location: Ave. Los Veteranos, Plaza Walmart Suite 103, Guayama, PR 00784 Phone: 787-686-0132 |
Dr. Mariher Mercedes Sobrino, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: Calle Esteban B Cruz, Suite #79-a, Guayama, PR 00784 Phone: 787-866-1777 |
Dr. Emilio Paez Chiropractic Center, Psc. Chiropractor Medicare: Medicare Enrolled Practice Location: Urb. Costa Azul, 2do Piso Suite 204 & 206, Guayama, PR 00784 Phone: 787-416-1560 Fax: 787-416-1563 |
News Archive
The South Australian Health Department is leading a community-based intervention program to successfully reduce antibiotics use for colds and flu.
Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. has initiated the treatment of the first patient in the second of two pivotal studies from the OBI-1's Accur8 clinical trial program.
Gilead Sciences Inc. announced Thursday that it plans to partner with Mylan Inc., Ranbaxy Laboratories Ltd. and Strides Arcolab Ltd. "to promote access to high-quality, low-cost generic versions of Gilead's HIV medicine emtricitabine in developing countries," the Wall Street Journal reports.
Despite sluggish economic growth and rapidly rising health care costs, Americans' access to needed medical care improved slightly between 2001 and 2003, especially among low-income children and adults, according to a national study released today by the Center for Studying Health System Change (HSC).
Gen-Probe announced today that the Company has submitted a Premarket Approval Application (PMA) to the US Food and Drug Administration (FDA) for its PROGENSA® PCA3 assay, a new molecular test that may help determine the need for repeat biopsies in men suspected of having prostate cancer.
› Verified 2 days ago